Jinxin Fertility Group Limited (JXR) has released an inside information announcement detailing a multi-year capital-return framework.

FY2025 final dividend • The Board has proposed a final dividend of RMB100.00 million (HKD113.20 million), equivalent to RMB0.0370 per share (HKD0.0418 per share). • The payout represents roughly 20% of the Group’s non-IFRS adjusted EBITDA for 2025 and is subject to approval at the upcoming annual general meeting.

2026-2028 shareholder return plan • For each of the next three financial years, the Company aims to return 50%–80% of non-IFRS adjusted EBITDA through a mix of dividends and share repurchases. • Capital-allocation decisions will prioritise on-market share repurchases when the trading price is viewed by the Board as materially below book value.

Immediate share-repurchase authorization • The Board has approved an on-market buyback of up to RMB300.00 million over the 12-month period starting 26 March 2026, subject to market conditions and regulatory compliance.

Amended dividend policy • Effective from 26 March 2026, not less than 20% of annual non-IFRS adjusted EBITDA will be distributed as cash dividends. • Based on reported figures, non-IFRS adjusted EBITDA stood at RMB707.30 million in 2024 and RMB491.10 million in 2025, implying potential dividend ranges of RMB141.46 million and RMB98.22 million, respectively, under the amended policy. • The Board retains discretion to revise or suspend the policy in response to operational or macroeconomic changes.

Governance provision Any force-majeure events or material shifts in business conditions may prompt adjustments to the return plan, with shareholder interests taking priority.

Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.